All GLG News Analyses Filed Under: Legal Issues

Depends on the jurisdiction. Many times the challenge is basaed on unconscionability. But don't count on it every place. It's a hot area that requires analysis by an attorney with a lot of experience. Comes up in credit card arbitration all the time. If there is any real interst in talking about the...

challenges to clauses that try to exculpate class action loability have been the subject of as lot of law suits and there is little agreement as to whether or not such a clause is unconscionable. This is an area that is constantly moving in all directions at once. Great care must be taken when trying...

Companies that have in essence contracts of adhesion may be able contractually set up a waiver of class action status? If this type of waiver is allowed do your rights to sue really exist?

The chances of SARBOX regulation being relaxed are nil.  However the chances of tighter regulation has been increased.

Stoneridge seems to offer a safe haven for some financial transactions under Rule 10 (b)! The way the decision is written, however, does not mean that this cloak of invincibility is available under all circumstances. 

The chances of loosening the knot of Sarbanes-Oxley will be diminished with the emergence of subprime problems. Will small companies still have a chance to fly under the radar of Sarbanes-Oxley?

In light of the subprime issues, any previous possibility of deregulating Sarbanes-Oxley has gone by the way side. Even the possibility of loosening the knot on smaller companies compliance has taken a back seat.

* As noted in the Wall Street Journal article, Aricept® is a blockbuster drug for the treatment of Alzheimer's disease.  And, as noted in Judge Ackerman's ruling, Aricept sales are a huge source of Eisai's revenue - "sales of Aricept® in the United States constitute 70% of Eisai’s...

Tessera's stock has been thoroughly trashed the last five weeks, in large part because the investment community saw one of TSRA's ITC cases temporarily derailed.  The next few days should bring a reprieve with respect to the ITC; but the real action is happening elsewhere in Washington: in publicly...

There was little reaction to the news last week that the Federal Circuit would not stay the pending BRCM injunction against QCOM.  But make no mistake: the BRCM fight is going poorly for QCOM, and there will be enormous pressure on QCOM to cut a deal later this year.